Pfizer rolls out Retacrit, a biosim to Amgen and J&J anemia blockbusters, at a big discount

14th November 2018 Uncategorised 0

Pfizer launched its third biosim, Retacrit, at a significant discount to anemia drugs from Amgen and Johnson & Johnson.

More: Pfizer rolls out Retacrit, a biosim to Amgen and J&J anemia blockbusters, at a big discount
Source: fierce